Af patienter i behandling med alendronat oplevede 48% færre en eller flere vertebrale frakturer (alendronat 3, 2% versus placebo 6, 2%) sammenlignet med patienter behandlet med placebo.
There was a 48% reduction (alendronate 3.2% vs placebo 6.2%) in the proportion of patients treated with alendronate experiencing one or more vertebral fractures relative to those treated with placebo.